About
Educational intelligence for the peptide era.
We help investors, researchers, students, and healthcare professionals understand publicly available peptide research and the companies developing peptide-based therapies.
What we do
Peptide Intelligence aggregates and organizes publicly available information about peptide therapeutics — the companies developing them, the clinical trials evaluating them, and the regulatory milestones that shape their approval. We focus on source-cited, verifiable information rather than speculation.
What we don't do
- • We do not sell peptides.
- • We do not prescribe treatments or recommend dosages.
- • We do not diagnose conditions.
- • We do not present ourselves as a medical provider.
- • We do not offer personalized investment advice.
- • We do not guarantee stock returns.
Our sources
We prioritize credible sources: government clinical-trial databases, FDA records, SEC filings, peer-reviewed medical journals, company investor-relations pages, official conference materials, patent databases, and recognized financial-data providers. See our data sources & methodology page for the full breakdown.
Editorial standards
Every scientific, medical, regulatory, and financial record carries a source field. We do not invent trial results, approvals, prices, partnerships, or catalyst dates. When live data is not connected, we display clearly labeled demonstration data.